Free Trial

UBS Group Increases Ambev (NYSE:ABEV) Price Target to $2.70

Ambev logo with Consumer Staples background

Ambev (NYSE:ABEV - Get Free Report) had its target price upped by investment analysts at UBS Group from $2.60 to $2.70 in a report released on Wednesday,Benzinga reports. The brokerage currently has a "neutral" rating on the stock. UBS Group's price objective indicates a potential upside of 8.43% from the stock's current price.

ABEV has been the topic of a number of other research reports. Wall Street Zen initiated coverage on shares of Ambev in a report on Wednesday, April 23rd. They set a "buy" rating on the stock. Barclays raised their target price on Ambev from $2.00 to $2.50 and gave the stock an "equal weight" rating in a research report on Monday, May 12th. Finally, Morgan Stanley cut Ambev from an "equal weight" rating to an "underweight" rating in a research note on Monday, April 7th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat, Ambev currently has a consensus rating of "Hold" and an average target price of $2.60.

Check Out Our Latest Report on ABEV

Ambev Price Performance

Ambev stock traded up $0.03 during mid-day trading on Wednesday, hitting $2.49. The company's stock had a trading volume of 30,155,476 shares, compared to its average volume of 29,519,886. The stock has a market capitalization of $39.24 billion, a P/E ratio of 13.83, a P/E/G ratio of 5.80 and a beta of 0.76. Ambev has a twelve month low of $1.76 and a twelve month high of $2.64. The stock's fifty day moving average price is $2.43 and its two-hundred day moving average price is $2.17. The company has a quick ratio of 0.89, a current ratio of 1.20 and a debt-to-equity ratio of 0.02.

Ambev (NYSE:ABEV - Get Free Report) last announced its earnings results on Thursday, May 8th. The company reported $0.04 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.04. The company had revenue of $3.92 billion for the quarter, compared to analyst estimates of $22.40 billion. Ambev had a return on equity of 16.12% and a net margin of 17.02%. Research analysts forecast that Ambev will post 0.18 earnings per share for the current year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of ABEV. State of Wyoming lifted its holdings in shares of Ambev by 11.3% during the 1st quarter. State of Wyoming now owns 39,606 shares of the company's stock valued at $92,000 after buying an additional 4,030 shares during the last quarter. Tranquilli Financial Advisor LLC raised its position in Ambev by 37.3% during the first quarter. Tranquilli Financial Advisor LLC now owns 20,943 shares of the company's stock valued at $49,000 after acquiring an additional 5,685 shares in the last quarter. NewEdge Advisors LLC lifted its stake in Ambev by 51.4% in the fourth quarter. NewEdge Advisors LLC now owns 17,084 shares of the company's stock valued at $32,000 after acquiring an additional 5,798 shares during the last quarter. IFP Advisors Inc grew its position in Ambev by 7.5% in the fourth quarter. IFP Advisors Inc now owns 84,868 shares of the company's stock worth $157,000 after acquiring an additional 5,900 shares in the last quarter. Finally, Mondrian Investment Partners LTD grew its position in Ambev by 40.4% in the fourth quarter. Mondrian Investment Partners LTD now owns 20,810 shares of the company's stock worth $38,000 after acquiring an additional 5,993 shares in the last quarter. Hedge funds and other institutional investors own 8.13% of the company's stock.

About Ambev

(Get Free Report)

Ambev SA, through its subsidiaries, engages in the production, distribution, and sale of beer, draft beer, carbonated soft drinks, malt and food, other alcoholic beverages, and non-alcoholic and non-carbonated products in Brazil, Central America and Caribbean, Latin America South, and Canada. It offers beer primarily under the Skol, Brahma, Antarctica, Brahva, Budweiser, Bud Light, Beck, Leffe, Hoegaarden, Balboa ICE, Balboa, Atlas Golden Light, Atlas, Bucanero, Cristal, Mayabe, Presidente, Presidente Light, Brahma Light, Bohemia, The One, Corona, Modelo Especial, Stella Artois, Quilmes Clásica, Paceña, Taquiña, Huari, Becker, Cusqueña, Michelob Ultra, Busch, Pilsen, Ouro Fino, Bud 66, Banks, Deputy, Patricia, Labatt Blue, Alexander Keith's, and Kokanee brands.

Read More

Analyst Recommendations for Ambev (NYSE:ABEV)

Should You Invest $1,000 in Ambev Right Now?

Before you consider Ambev, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ambev wasn't on the list.

While Ambev currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Cheap Growth Stocks Set to Explode This Summer
The Next NVIDIA? Quantum Computing Stocks Set for Explosive Growth
5 Stocks to BUY NOW in July 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines